相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
Elahe A. Mostaghel et al.
CLINICAL CANCER RESEARCH (2011)
Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
Emma Hornberg et al.
PLOS ONE (2011)
A Snapshot of the Expression Signature of Androgen Receptor Splicing Variants and Their Distinctive Transcriptional Activities
Rong Hu et al.
PROSTATE (2011)
Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer
Meng-Lei Zhu et al.
CANCER RESEARCH (2010)
Identification of Novel Truncated Androgen Receptor (AR) Mutants Including Unreported Pre-mRNA Splicing Variants in the 22Rv1 Hormone-Refractory Prostate Cancer (PCa) Cell Line
Gemma Marcias et al.
HUMAN MUTATION (2010)
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Treatment-Dependent Androgen Receptor Mutations in Prostate Cancer Exploit Multiple Mechanisms to Evade Therapy
Mara P. Steinkamp et al.
CANCER RESEARCH (2009)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Protease-Activated Receptor-1 is Upregulated in Reactive Stroma of Primary Prostate Cancer and Bone Metastasis
Xiaotun Zhang et al.
PROSTATE (2009)
Mechanisms mediating androgen receptor reactivation after castration
Xin Yuan et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer
Jennifer A. Locke et al.
CANCER RESEARCH (2008)
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
R. Bruce Montgomery et al.
CANCER RESEARCH (2008)
Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteins
Ramneet Kaur et al.
PROSTATE (2008)
Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases
Colm Morrissey et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
A splicing variant of the androgen receptor detected in a metastatic prostate cancer exhibits exclusively cytoplasmic actions
Monika Jagla et al.
ENDOCRINOLOGY (2007)
An androgen-IL-6-Stat3 autocrine loop re-routes EGF signal in prostate cancer cells
David S. Aaronson et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: Therapeutic implications for castration-resistant prostate cancer
Elahe A. Mostaghel et al.
CANCER RESEARCH (2007)
Interaction of IGF signaling and the androgen receptor in prostate cancer progression
Jennifer D. Wu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells
Xin Yuan et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer
M Stanbrough et al.
CANCER RESEARCH (2006)
Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization
D Gioeli et al.
MOLECULAR ENDOCRINOLOGY (2006)
Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
HI Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors
JD Wu et al.
CLINICAL CANCER RESEARCH (2005)
Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence
ME Taplin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
The androgen axis in recurrent prostate cancer
JL Mohler et al.
CLINICAL CANCER RESEARCH (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone
MP Roudier et al.
HUMAN PATHOLOGY (2003)
The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions
CA Heinlein et al.
MOLECULAR ENDOCRINOLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
